Profile data is unavailable for this security.
About the company
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.
- Revenue in CAD (TTM)11.25bn
- Net income in CAD59.05m
- Incorporated2013
- Employees19.60k
- LocationBausch Health Companies Inc2150 Saint-Elzear Blvd WLAVAL H7L 4A8CanadaCAN
- Phone+1 (514) 744-6792
- Fax+1 (514) 744-6792
- Websitehttps://www.bauschhealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cronos Group Inc | 129.49m | -149.21m | 1.48bn | 626.00 | -- | 0.829 | -- | 11.44 | -0.3967 | -0.3964 | 0.3458 | 4.68 | 0.0595 | 2.17 | 6.15 | 206,848.70 | -6.89 | 13.51 | -7.45 | 15.39 | 13.00 | -36.30 | -115.91 | 421.25 | 25.16 | -- | 0.00 | -- | 59.32 | 181.87 | -445.76 | -- | 60.54 | -- |
| BELLUS Health Inc | 21.97k | -97.19m | 1.53bn | 40.00 | -- | 4.17 | -- | 69,486.98 | -1.07 | -1.07 | 0.0002 | 3.39 | 0.00008 | -- | 0.0308 | 549.28 | -34.50 | -29.27 | -37.09 | -30.98 | -- | -- | -442,331.30 | -64,780.43 | -- | -- | 0.0027 | -- | 6.67 | -59.28 | -124.28 | -- | -- | -- |
| Canopy Growth Corp | 494.23m | -2.78bn | 1.83bn | 3.15k | -- | 0.9302 | -- | 3.70 | -6.99 | -6.99 | 1.25 | 4.05 | 0.0943 | 2.32 | 5.93 | 156,848.90 | -53.38 | -15.43 | -57.02 | -16.65 | -44.85 | -5.45 | -566.13 | -234.00 | 3.43 | -9.84 | 0.4864 | -- | -4.82 | 67.14 | 82.68 | -- | 10.25 | -- |
| Bausch Health Companies Inc | 11.25bn | 59.05m | 3.67bn | 19.60k | 62.81 | -- | 1.78 | 0.3266 | 0.16 | 0.16 | 31.09 | -2.63 | 0.2815 | 2.16 | 5.04 | 573,941.60 | 0.1993 | -3.50 | 0.2485 | -4.07 | 71.48 | 71.80 | 0.708 | -14.22 | 0.8693 | 1.00 | 0.9885 | -- | 5.07 | -2.71 | -69.29 | -- | -0.556 | -- |
